12:35 , May 8, 2019 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: April 2019

New Therapeutic Targets and Biomarkers: April 2019 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during April. Therapeutic targets are defined as any protein, gene or other molecule...
13:56 , Apr 10, 2019 |  BC Innovations  |  Distillery Therapeutics

Blocking the ATAD3A-DNM1L interaction for HD

DISEASE CATEGORY: Neurology INDICATION: Huntington disease (HD) Cell culture and mouse studies identified an inhibitor of ATAD3A-DNM1L interaction that could help treat HD. An in vitro assay for proteins that bind DNM1L identified ATAD3A as...